Nunc a mollis mauris
Men with higher visceral fat develop progressive insulin resistance, meaning their cells stop responding efficiently to insulin signals
Reported benefits (per available research): Studied for restoring more youthful pulsatile GH and IGF-1 secretion in older adults, based on a small 1997 randomized, placebo-controlled human trial of a closely related GHRH(1-29) analog published in the Journal of Clinical Endocrinology & Metabolism May support gains in lean body mass in men specifically: that same 16-week trial found a statistically significant increase in lean body mass in men but not in women, alongside a significant increase in skin thickness (a marker of dermal collagen) in both sexes Proposed to support broader recovery and body-composition goals tied to growth-hormone-axis activity, though sermorelin-specific modern adult trial data remains thin, and much of the anti-aging and muscle-building framing used in commercial marketing outpaces the current clinical evidence base Known risks and side effects: Injection-site reactions (pain, swelling, or redness) are the most commonly reported adverse event associated with sermorelin therapy in manufacturer drug-labeling data Headache, flushing, dizziness, difficulty swallowing, hyperactivity, drowsiness, and hives have also been reported less commonly per that same labeling data
facility Accompanied by a Certificate of Analysis (COA) Verified via HPLC and mass spectrometry Shipped securely with quality-control documentation Contents: 10mg Thymalin lyophilized peptide Appearance: White to off-white crystalline powder Solubility: Reconstitute with sterile bacteriostatic water Storage: Store lyophilized at -20C
They have not been cleared by regulatory bodies such as the FDA for rarefied use in humans
Sermorelin Peptide Injection is a short chain peptide consisting of 29 amino acids, whose sequence is identical to the amino terminal fragment of endogenous growth hormone releasing hormone (GHRH) in the human body
